S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

APTO Aptose Biosciences Inc

0.2851

0.012 (4.39%)

Pre Market

Last Updated: 07:06:37

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Aptose Biosciences Charts.

Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Aptose Biosciences Charts.

Aptose Biosciences Inc News

Form 8-K - Current report
Wednesday 20 November 2024 (1 day ago) • Edgar (US Regulatory)

Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
Wednesday 20 November 2024 (1 day ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Aptose Reports Results for the Third Quarter 2024
Friday 8 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Thursday 31 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 4 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 6 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 September 2024 (3 months ago) • Edgar (US Regulatory)

Aptose Announces Results from Special Meeting of Shareholders
Thursday 5 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 30 August 2024 (3 months ago) • Edgar (US Regulatory)

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
Friday 30 August 2024 (3 months ago) • GlobeNewswire Inc.

More Aptose Biosciences Inc News Articles

Quantum Computing

Sincerity Applied Materi... (PK)

Net Savings Link (PK)

Asia Broadband (PK)

TheGlobe com (PK)

Apple Rush (PK)

NioCorp Developments

Accredited Solutions (PK)

Baron Capital Enterprise (CE)

Rennova Health (CE)

Hannover House (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions